Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis

Frontiers in Immunology - Tập 10
Jonel Trebicka1,2,3,4,5, Àlex Amorós3, Carla Pitarch3, Esther Titos6, José Alcaraz‐Quiles6, Robert Schierwagen1,5, Carmen Deulofeu3, Javier Fernandez-Gomez7, Salvatore Piano8, Paolo Caraceni9, Karl Oettl10, Elsa Solà7, Wim Laleman11, Jane McNaughtan12, Rajeshwar P. Mookerjee12, Minneke J. Coenraad13, Tania M. Welzel5, Christian J. Steib14, Rita García‐Martínez15, Thierry Gustot16, Miguel Ángel Rodríguez-Gandía17, Rafael Bañares15, Agustı́n Albillos17, Stefan Zeuzem5, Vı́ctor Vargas18, Faouzi Saliba19, F. Nevens11, Carlo Alessandria20, Andrea De Gottardi21, Heinz Zoller22, Pere Ginès7, Tilman Sauerbruch1, Alexander L. Gerbes14, Rudolf Stauber10, Mauro Bernardi9, Paolo Angeli8, Marco Pavesi3, Richard Moreau3,23,24,25,26, J. J. Clariá6,3, Vicente Arroyo3
1Department of Internal Medicine I, University of Bonn, Bonn, Germany
2Department of Mechanical Biology, Institute for Bioengineering of Catalonia, Barcelona, Spain
3European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain
4Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
5J. W. Goethe University Hospital, Frankfurt, Germany
6Department of Biochemistry and Molecular Genetics, Hospital Clínic, IDIBAPS and CIBERehd, Barcelona, Spain
7Liver Unit, Hospital Clínic, IDIBAPS and CIBERehd, Barcelona, Spain
8Unit of Internal Medicine and Hepatology, Department of Medicine, DIMED, University of Padova, Padova, Italy
9Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
10Department of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria
11University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium
12ROYAL FREE HOSPITAL, LONDON, United Kingdom
13Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
14Department of Medicine II, Liver Center Munich, University Hospital LMU Munich, Munich, Germany
15Department of Digestive Diseases and CIBERehd, Facultad de Medicina, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain
16Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
17Hospital Ramón y Cajal, Madrid, Spain
18Vall d’Hebron Hospital, Barcelona, Spain
19Hôpital Paul Brousse, Université Paris-Sud, Villejuif, France
20Division of Gastroenterology and Hepatology, San Giovanni Battista Hospital, Torino, Italy
21Department of Hepatology, Inselspital, Bern, Switzerland
22Department of Hepatology and Gastroenterology, University Clinic Innsbruck, Innsbruck, Austria
23Inserm, U1149, Centre de Recherche sur l'Inflammation (CRI), UMRS1149, Paris, France
24Laboratoire d’Excellence Inflamex, ComUE Sorbonne Paris Cité, Paris, France
25Service d'Hépatologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Paris, France
26Université Paris Diderot-Paris 7, Département Hospitalo-Universitaire (DHU) UNITY, Paris, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042

Arroyo, 2015, Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis, J Hepatol, 62, S131, 10.1016/j.jhep.2014.11.045

Arroyo, 2016, Acute-on-chronic liver failure in cirrhosis, Nat Rev Dis Primers, 2, 16041, 10.1038/nrdp.2016.41

Hernaez, 2017, Acute-on-chronic liver failure: an update, Gut, 66, 541, 10.1136/gutjnl-2016-312670

Clària, 2016, Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure, Hepatology, 64, 1249, 10.1002/hep.28740

Solé, 2016, Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis, Sci Rep, 6, 32341, 10.1038/srep32341

Grønbæk, 2016, Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF), J Hepatol, 64, 813, 10.1016/j.jhep.2015.11.021

Ariza, 2016, Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis, J Hepatol, 65, 57, 10.1016/j.jhep.2016.03.002

Jansen, 2017, Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality, Hepatology, 67, 1472, 10.1002/hep.29612

Lehmann, 2017, Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality, Liver Int, 38, 875, 10.1111/liv.13610

Tan, 2018, Genome-wide association study identifies HLA-DR variants conferring risk of HBV-related acute-on-chronic liver failure, Gut, 67, 757, 10.1136/gutjnl-2016-313035

Bernsmeier, 2018, CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure, Gut, 67, 1155, 10.1136/gutjnl-2017-314184

Berzigotti, 2013, Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis, Gastroenterology, 144, 102, 10.1053/j.gastro.2012.10.001

Angeli, 2018, EASL Clinical practice guidelines for the management of patients with decompensated cirrhosis, J Hepatol., 69, 406, 10.1016/j.jhep.2018.03.024

de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: Stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022

Bernardi, 2015, Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis, J Hepatol, 63, 1272, 10.1016/j.jhep.2015.07.004

Thursz, 2015, The clinical effectiveness and cost-effectiveness of STeroids or pentoxifylline for alcoholic hepatitis (stopah): a 2 × 2 factorial randomised controlled trial, Health Technol Assess, 19, 1, 10.3310/hta191020

Hendy, 2016, Pentoxifylline is ineffective in treating severe alcoholic hepatitis, Frontline Gastroenterol, 7, 80, 10.1136/flgastro-2015-100615

Akriviadis, 2000, Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 1637, 10.1053/gast.2000.20189

Lebrec, 2010, Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis, Gastroenterology, 138, 1755, 10.1053/j.gastro.2010.01.040

Dubuquoy, 2015, Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis, Gut., 64, 1949, 10.1136/gutjnl-2014-308410

Alcaraz-Quiles, 2017, Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure, Hepatology, 65, 202, 10.1002/hep.28896

Domenicali, 2014, Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis, Hepatology, 60, 1851, 10.1002/hep.27322

Sort, 1999, Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis, N Engl J Med, 341, 403, 10.1056/NEJM199908053410603

Caraceni, 2018, Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial, Lancet, 391, 2417, 10.1016/S0140-6736(18)30840-7

Garg, 2012, Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure, Gastroenterology, 142, 505, 10.1053/j.gastro.2011.11.027

Thông tin
Thông tin xuất bản

Frontiers in Immunology

Tập 10

Thông tin tác giả